Oculoosteocutaneous syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2713OMIM:211370Q87.5
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculoosteocutaneous syndrome is a very rare condition that affects three main parts of the body: the eyes (oculo), the bones (osteo), and the skin (cutaneous). It is sometimes referred to by the abbreviation OOCS. People with this syndrome are typically born with a combination of eye problems, unusual bone development, and skin changes that appear together as a recognizable pattern. The eye problems can include structural abnormalities that affect vision from birth or early infancy. Bone changes may affect the shape or density of certain bones, and skin findings can include unusual pigmentation or texture changes visible at or shortly after birth. Because all three body systems are involved at once, this is considered a multi-system condition. Treatment is focused on managing each symptom individually, since there is currently no cure. Eye specialists, bone specialists, and skin specialists often work together as a team to support affected individuals. Early diagnosis is important so that vision problems and other complications can be addressed as soon as possible to give the best quality of life.

Key symptoms:

Eye structural abnormalities present from birthReduced or absent vision in one or both eyesUnusual bone shape or densitySkin color changes or unusual skin textureAbnormal appearance of the eyelids or eye socketPossible small or underdeveloped eyes (microphthalmia)Skin lesions or patches present at birth

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Oculoosteocutaneous syndrome.

View clinical trials →

No actively recruiting trials found for Oculoosteocutaneous syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Oculoosteocutaneous syndrome community →

No specialists are currently listed for Oculoosteocutaneous syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Oculoosteocutaneous syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Oculoosteocutaneous syndromeForum →

No community posts yet. Be the first to share your experience with Oculoosteocutaneous syndrome.

Start the conversation →

Latest news about Oculoosteocutaneous syndrome

No recent news articles for Oculoosteocutaneous syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic tests should we do to confirm the diagnosis and identify the specific gene involved?,How often should my child have eye exams, and what vision treatments are available?,Are there bone complications we should watch for, and how will they be monitored?,Should other family members be tested or evaluated?,Are there any clinical trials or research studies we could participate in?,What early intervention or educational support services would you recommend?,Which specialists should be part of our care team, and how do we coordinate between them?

Common questions about Oculoosteocutaneous syndrome

What is Oculoosteocutaneous syndrome?

Oculoosteocutaneous syndrome is a very rare condition that affects three main parts of the body: the eyes (oculo), the bones (osteo), and the skin (cutaneous). It is sometimes referred to by the abbreviation OOCS. People with this syndrome are typically born with a combination of eye problems, unusual bone development, and skin changes that appear together as a recognizable pattern. The eye problems can include structural abnormalities that affect vision from birth or early infancy. Bone changes may affect the shape or density of certain bones, and skin findings can include unusual pigmentati

How is Oculoosteocutaneous syndrome inherited?

Oculoosteocutaneous syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Oculoosteocutaneous syndrome typically begin?

Typical onset of Oculoosteocutaneous syndrome is neonatal. Age of onset can vary across affected individuals.